Cas:892502-19-1 4-methyl-2-pyridin-4-yl-1,3-thiazole-5-carbaldehyde manufacturer & supplier

We serve Chemical Name:4-methyl-2-pyridin-4-yl-1,3-thiazole-5-carbaldehyde CAS:892502-19-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-methyl-2-pyridin-4-yl-1,3-thiazole-5-carbaldehyde

Chemical Name:4-methyl-2-pyridin-4-yl-1,3-thiazole-5-carbaldehyde
CAS.NO:892502-19-1
Synonyms:4-methyl-2-pyridin-4-yl-1,3-thiazole-5-carbaldehyde
Molecular Formula:C10H8N2OS
Molecular Weight:204.24800
HS Code:

Physical and Chemical Properties:
Melting point:168.5-170ºC
Boiling point:406.1ºC at 760 mmHg
Density:1.287g/cm3
Index of Refraction:1.637
PSA:71.09000
Exact Mass:204.03600
LogP:2.32600

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-methyl-2-pyridin-4-yl-1,3-thiazole-5-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-methyl-2-pyridin-4-yl-1,3-thiazole-5-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-methyl-2-pyridin-4-yl-1,3-thiazole-5-carbaldehyde Use and application,4-methyl-2-pyridin-4-yl-1,3-thiazole-5-carbaldehyde technical grade,usp/ep/jp grade.


Related News: The company forecasts that the 70-strong team will grow by around 50% in the next three years to support its clinical and commercial API manufacturing capabilities. methyl (E)-2-(N-(3-((4-chlorophenyl)sulfonamido)propyl)-N-(3-(2-(4-cyclobutylthiazol-2-yl)vinyl)benzyl)sulfamoyl)benzoate manufacturers GSK picked McNamara after six months of “extensive search and selection process,” GSK said in its announcement Thursday. It ran the quest with help from two headhunters and evaluated “several external and internal candidates,” it said. 5,8,11,14,17,20,23-hepta(propan-2-ylidene)cyclotricosa-1,3,6,9,12,15,18,21-octayne suppliers Wavelength Pharmaceuticals will pay an undisclosed sum to buy up a majority stake in Hyderabad’s Vanamali Organics, an Indian firm specializing in making drug intermediates and starting materials that will add to Wavelengths’ API contract manufacturing work, the company said in a release. 6-(4-(6-((13,23,33,43,53-pentaoxol-2-yl)oxy)-13,23,34,43,53,64-hexaoxin-3-yl)-13,24,33,44-pentaoxol-2-yl)-13,23,34,43,53,64-hexaoxin-3-ol vendor & factory.